Main Content
latest…
BSM Technologies is a buy, Laurentian Bank Securities says
BSM Technologies (TSX:GPS) produced a revenue beat over its fiscal third quarter, enough for analyst … Keep reading
More recent headlines
Cannabis
Canopy Growth Corp. gets new $60.00 price target at PI Financial
Canopy Growth Corp’s (TSX:WEED, NYSE:CGC) new buy-in from liquor company Constellation Brands will be key to the licensed cannabis producer’s build … Read More
See related
Stock Picks
BSM Technologies is a buy, Laurentian Bank Securities says
BSM Technologies (TSX:GPS) produced a revenue beat over its fiscal third quarter, enough for analyst Nick Agostino of Laurentian Bank Securities to … Read more
See related
Life Sciences Stocks
“Disappointing” Centric Health is still a buy, says Echelon Wealth Partners
Analyst Doug Loe of Echelon Wealth Partners is more cautious about Centric Health (TSX:CHH) after … Keep reading
Profound Medical Corp. has a potential game-changer on its hands, Paradigm Capital says
Investors may be disappointed with Profound Medical Corp’s (TSX:PRN) second quarter results, but … Keep reading
Promis Neurosciences has 79 per cent upside, says Mackie Research
After publishing its second quarter results, Canadian biotech company Promis Neurosciences (TSX:PMN) … Keep reading
Viemed Healthcare has 83 per cent upside, Beacon Securities says
Medical equipment supply company Viemed Healthcare (TSX:VMD) posted revenue and EBITDA beats in its … Keep reading
Acerus Pharma has huge upside, Mackie Research says
Analyst André Uddin of Mackie Research Capital says the market dynamics in the United States for … Keep reading